AdvisorShares Trust 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-05 12:39 pm Purchase | 2025-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 16,974 1.660% | 1 (+0.00%) | Filing |
| 2025-10-03 5:51 pm Purchase | 2025-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 16,973 6.270% | 9,446 (+125.50%) | Filing |
| 2025-04-02 4:12 pm Purchase | 2025-03-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 7,527 3.650% | 7,305 (+3287.97%) | Filing |
| 2025-01-06 5:04 pm Purchase | 2024-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 222 5.900% | 86 (+63.43%) | Filing |
| 2024-11-12 1:43 pm Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 136 4.110% | 93 (+215.62%) | Filing |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 43 5.600% | 43 (New Position) | Filing |